NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.

Marta Vives-Pi , Silvia Rodriguez-Fernandez , Aina Teniente-Serra , Jacobo Perez
Frontiers in Immunology 11 611522 -611522

2021
Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.

Silvia Rodriguez-Fernandez , Irma Pujol-Autonell , Ferran Brianso , David Perna-Barrull
Frontiers in Immunology 9 253 -253

53
2018
Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes.

Adrian Villalba , Silvia Rodriguez-Fernandez , Rosa-Maria Ampudia , Mary Cano-Sarabia
Artificial Cells Nanomedicine and Biotechnology 48 ( 1) 77 -83

2
2020
Strong Artificial Selection in Domestic Mammals Did Not Result in an Increased Recombination Rate

Violeta Muñoz-Fuentes , Marina Marcet-Ortega , Gorka Alkorta-Aranburu , Catharina Linde Forsberg
Molecular Biology and Evolution 32 ( 2) 510 -523

26
2015
Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study.

Adrian Villalba , Mireia Fonolleda , Marta Murillo , Silvia Rodriguez-Fernandez
Translational Research 210 8 -25

4
2019
Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential.

Silvia Rodriguez-Fernandez , Marta Murillo , Adrian Villalba , David Perna-Barrull
Frontiers in Immunology 10 2811 -2811

6
2019
Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes.

David Perna-Barrull , Silvia Rodriguez-Fernandez , Irma Pujol-Autonell , Anna Gieras
Scientific Reports 9 ( 1) 1235

2
2019
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.

Adrian Villalba , Silvia Rodriguez-Fernandez , David Perna-Barrull , Rosa-Maria Ampudia
Frontiers in Endocrinology 11 258 -258

4
2020
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes.

Adrian Villalba , Silvia Rodriguez-Fernandez , David Perna-Barrull , Rosa-Maria Ampudia
Scientific Reports 10 ( 1) 18927 -18927

2020
A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation

Adrian Villalba , Yorick Gitton , Megumi Inoue , Virginie Aiello
Diabetologia 67 ( 6) 1066 -1078

2024
A letter to the article “Whole Body Gestational Donation” published by Anna Smajdor in Theoretical Medicine and Bioethics

Gonzalo Díaz-Cobacho , Adrian Villalba
Theoretical Medicine and Bioethics 44 ( 4) 375 -378

2
2023
Synthetic embryos: a new venue in ethical research

Adrian Villalba , Jon Rueda , Íñigo de Miguel Beriain
Reproduction 165 ( 4) V1 -V3

5
2023
Human stem-cell-derived embryo models: When bioethical normativity meets biological ontology

Adrian Villalba , Jon Rueda , Íñigo De Miguel Beriain
Developmental Biology 508 88 -92

2024
Pancreatic islet cells response to IFNγ relies on their spatial location within an islet

Marine De Burghgrave , Chloé Lourenço , Claire Berthault , Virginie Aiello
Cells 12 ( 1) 113 -113

3
2022
The ethics of cellular reprogramming

Anna Smajdor , Adrian Villalba
Cellular Reprogramming 25 ( 5) 190 -194

1
2023
Corrigendum: NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes

Laia Gomez-Muñoz , David Perna-Barrull , Adrian Villalba , Silvia Rodriguez-Fernandez
Frontiers in Immunology 15 1439246 -1439246

2024
Re-defining the human embryo: A legal perspective on the creation of embryos in research

Íñigo De Miguel Beriain , Jon Rueda , Adrián Villalba
EMBO Reports

2
2024